MWA Asset Management’s iShares Russell Mid-Cap Growth ETF IWP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Sell
14,614
-223
-2% -$30.7K 0.97% 30
2026
Q1
$1.9M Buy
14,837
+179
+1% +$24.2K 1.04% 27
2025
Q4
$2.01M Sell
14,658
-382
-3% -$53.4K 1.12% 26
2025
Q3
$2.14M Sell
15,040
-233
-2% -$32.9K 1.18% 25
2025
Q2
$2.12M Sell
15,273
-651
-4% -$82.4K 1.3% 25
2025
Q1
$1.87M Buy
15,924
+368
+2% +$47.3K 1.3% 23
2024
Q4
$1.97M Buy
15,556
+63
+0.4% +$8.01K 1.31% 21
2024
Q3
$1.82M Buy
15,493
+190
+1% +$21.2K 1.21% 25
2024
Q2
$1.69M Sell
15,303
-11
-0.1% -$1.21K 1.2% 30
2024
Q1
$1.75M Buy
15,314
+441
+3% +$47.7K 1.27% 24
2023
Q4
$1.55M Buy
14,873
+382
+3% +$36.2K 1.28% 26
2023
Q3
$1.32M Buy
+14,491
New +$1.39M 1.28% 23

Other funds holding IWP

MWA Asset Management's IWP Position: Q2 2026 in Review

MWA Asset Management reduced its iShares Russell Mid-Cap Growth ETF (IWP) stake by 1.5% in Q2 2026, selling an estimated $30.7K and leaving 14,614 shares worth $2.14M. The position accounts for 0.97% of the portfolio, ranked #30.

MWA Asset Management first reported a position in IWP in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.14M in Q3 2025. 1,222 funds tracked by Wall St. Rank hold IWP as of Q2 2026.

  • MWA Asset Management held 14,614 shares of iShares Russell Mid-Cap Growth ETF worth $2.14M as of Q2 2026.
  • MWA Asset Management sold 223 iShares Russell Mid-Cap Growth ETF shares in Q2 2026, an estimated $30.7K.
  • iShares Russell Mid-Cap Growth ETF made up 0.97% of MWA Asset Management's portfolio in Q2 2026, its #30 holding.
  • MWA Asset Management first reported a position in iShares Russell Mid-Cap Growth ETF in Q3 2023 and has held it in 12 quarters since.
  • MWA Asset Management's iShares Russell Mid-Cap Growth ETF position peaked at $2.14M in Q3 2025.
  • 1,222 funds tracked by Wall St. Rank held iShares Russell Mid-Cap Growth ETF as of Q2 2026.

Based on MWA Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.